Skip to main
PHR

Phreesia Inc (PHR) Stock Forecast & Price Target

Phreesia Inc (PHR) Analyst Ratings

Based on 15 analyst ratings
Buy
Strong Buy 20%
Buy 40%
Hold 40%
Sell 0%
Strong Sell 0%

Bulls say

Phreesia is fairly valued at its current levels with a CY27E EV/adjusted EBITDA multiple of 3.8x and a CY27E EV/FCF multiple of 9.1x. While the company's 15.9% Y/Y revenue growth in Q4F26 was above expectations, uncertainty around future growth rates and macroeconomic and competitive headwinds justify the discount to the peer group median. Furthermore, its heavy reliance on payment processing fees, which make up 37% of its revenue, leaves it vulnerable to any decline in patient visit volumes due to a potential future surge in COVID-19 cases.

Bears say

Phreesia is expected to face significant challenges in the coming years as they are experiencing stagnant growth in their largest revenue line and increasing competition for lower healthcare ad budgets. Additionally, the company's recent acquisition of AccessOne is not performing as well as expected and is heavily reliant on a few key clients. The company also faces risks in terms of changing regulations and potential privacy and security breaches. These challenges are expected to dampen the company's growth and profitability, causing concern for investors and leading to a negative outlook on the stock.

Phreesia Inc (PHR) has been analyzed by 15 analysts, with a consensus rating of Buy. 20% of analysts recommend a Strong Buy, 40% recommend Buy, 40% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Phreesia Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Phreesia Inc (PHR) Forecast

Analysts have given Phreesia Inc (PHR) a Buy based on their latest research and market trends.

According to 15 analysts, Phreesia Inc (PHR) has a Buy consensus rating as of May 20, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $17.67, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $17.67, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Phreesia Inc (PHR)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.